A rapid, decentralized search engine grants access to data without revealing sensitive details. Through a combination of zero-knowledge proofs and partially homomorphic encryption schemes, Atanaâs zero-knowledge query language allows users to search for specific data fields and their associated identities without revealing the contents of the data nor the identities themselves.
Secured Computation Engine
A lightweight infrastructure addresses concerns of data security without requiring a massive technological overhaul. By utilizing a combination of hardware and software security modules, enterprise data and analytic tools can interact and produce results while staying encrypted. Users have the ability to pick their computation service providers based on price, security credentialing, and reputation.
Private Algorithm Analysis
A private analysis framework allows AI algorithms to run on data without revealing the data in the process. Sensitive data and proprietary algorithms are encrypted throughout the entire process. This lowers the barrier to valuable data for A.I. developers and increases the willingness of data owners in traditionally slow-moving industries, such as healthcare, to adopt a more open door policy.
Interoperable Data Oracle
An interoperable data oracle provides a way for enterprise to access both structured and unstructured data from external and internal sources. These services, offered as a suite of secure APIs allow developers to include analytics in their edge and mobile devices, powering intelligent IoT, and providing versatile ways of transacting data from a wide network of external and internal sources.
Flexible graph model of data objects and their relationships with immutable state management by public blockchain means many different types of data can be integrated and transferred while guaranteeing their status at any given point.
Any off-chain storage mechanisms can be incorporated into on-chain data models with minimal integration effort.
Scalable Business Intelligence
Users can integrate building blocks to develop and publish powerful business intelligence tools and platforms. As a result, anyone from a developer to an executive can leverage the full potential of their organizationâs data. From formatting information into multiple data warehouses to running real-time projections, users can easily share, modify, and execute information-pipelines across high-performance channels. This enables companies to adopt a flexible pay-as-you-go model for analytics rather than making significant investments of time, money, and labor with each pivot.
An Ecosystem to Power Modern Data Infrastructure
Query encrypted databases of providers and payers
Secret contracts guarantee security of IP partitions
Interoperable, granular credentials for private data
Propose, fund, and create intellectual property
Leverage network data using extensible APIâs
Exchange analysis to build data-driven applications
The Atana platform provides incentive structures to encourage decentralized healthcare collaboration and application development, advancing a reproducible and extensible scientific paradigm.
All information in this contact form is collected in accordance with the 619-688-9574.
Atanaâs team has over 50+ years of combined experience across the Stanford and Johns Hopkins University communities.
Led multiple M&A transactions. Technical consultant for Aeternity Blockchain. Advisor for blockchain companies. Awarded by Booz Allen Hamilton and J.P. Morgan for blockchain implementations. Johns Hopkins University.
10 years in academic and industry R&D. Led the data science team at a FDA-approved digital therapeutic startup, focusing on creating compliant APIs and a data science platform for AI-driven analyses. Johns Hopkins University.
Co-created a community-facing care coordination system for value-based care. Led special operations at PCCI and created growth strategy for provider-facing clinical A.I. software at Pieces Technologies. Stanford University.
Creator of open-source data analytics packages with emphasis on dimensionality reduction, dependence testing, and graph inference. Co-created pipeline for hyper-parallelization of dMRI and fMRI connectomics. Johns Hopkins University.
Assistant Professor at the Johns Hopkins University and the JHU Information Security Institute. Creator of the Zerocoin protocol and developed the first zk-SNARK implementation in a cryptocurrency. Founding scientist of Zcash. Co-founder and former partner at Independent Security Evaluators.
Professor Green studied computer science at Oberlin College and received his doctorate degree in computer science from the Johns Hopkins University.
Professor of Applied Economics at the Johns Hopkins University and Director of the Johns Hopkins Institute for Applied Economics and Global Health. Formerly Senior Economist to President Reagan's Council of Economic Advisors and Senior Advisor to the Joint Economic Committee of the U.S. Congress. Senior Fellow and Director of the Troubled Currencies Project at the Cato Institute, Senior Advisor to China's International Monetary Research Institute. Former State Counselor to Lithuania and Montenegro, and Advisor to the Presidents of Bulgaria, Venezuela, and Indonesia. Reformed currencies and advised governments of many states including Argentina, the United Arab Emirates, Estonia, Kazakhstan, and Russia.
Professor Hanke studied business administration and received his doctorate degree in economics from the University of Colorado.
Chief Innovation Officer and former Senior Vice President of Research and Development at Evolent Health. Dr. Cattrell holds a PhD in Clinical Epidemiology from Harvard University and has spent that last 10 years building risk models and evaluating the impact of clinical programs for the National Institutes of Health, the Department of Defense, the Centers for Disease Control, and USAID. Prior to joining Evolent, Dr. Cattrell served as a Senior Associate at Booz Allen Hamilton building the firmâs Evaluation Practice and prior to that was the Director of Monitoring and Evaluation for Partners in Health, Rwanda.
Dr. Cattrell studied biomedical engineering at Northwestern University and received her masterâs degree in biomedical engineering and doctorate degree in epidemiology from Harvard University.
Executive Vice President of Utilization Management at eviCore. Matt oversees strategic transformation of utilization management business with a focus on reducing burden of prior authorization process through EHR connectivity, integration of natural language and advanced data science techniques to automate administrative and clinical processes and developing value added services designed assist in evidence based clinical decision making at the point of care. Matt joined eviCore in 2004 as the Director of Call Center Operations. During his tenure at eviCore, he has also served as SVP of Value Improvement Programs, SVP of Information Technology, SVP of Program Operations, SVP of Call Center Operations, and VP of Management Engineering. Prior to joining eviCore, Matt served as an Infantry Officer in the U.S. Army for nearly nine years.
Matt studied civil engineering at the United States Military Academy at West Point.
COO at Riot Blockchain. Previously COO at Dunbar and founder of Dunbarâs cybersecurity business. Experienced cybersecurity executive and creator of the Cyphon enterprise cybersecurity platform. Virginia Tech.
Chris studied computer engineering at Virginia Tech University.
President and CEO at QPID Health (acquired by Evicore). Prior to QPID, Mike was CEO and Chairman of Medsphere Systems Corporation, the developer of OpenVista, an open-source enterprise electronic health record system whose basic source code originated at the VA. While President and CEO of Advantedge Health Solutions, he led the rapid expansion of a cloud based physician revenue cycle management solution for hospital-based physicians. As founder, CEO, and President of Standish Care (CareMatrix), a company he brought public, Mike created the âassisted livingâ category of long term care. He previously held senior leadership positions with two major integrated healthcare delivery systems: Voluntary Hospitals of America (VHA) and National Medical Enterprises (Tenet).
Mike studied biology and community health at Tufts University and received his MBA in finance and hospital administration from the University of Chicago.
Senior Vice President of Outcome Health. At Outcome Health, Dr. Sawhney leads their corporate strategy and go-to-market efforts and manages their $100M venture fund. He has developed $25M+ of business relationships for Outcome, including Medisafe, Vivify, Novartis, Bayer, Amgen, Celgene, Gilead, and AbbVie. Before Outcome, Dr. Sawhney served as a partner in Bain's private equity and healthcare division, leading strategy for payers and life sciences firms as well as investment strategy for Bain's healthcare Partner Fund. He has also served as the SVP and head of corporate strategy at Novartis Pharmaceuticals, where he led mergers and acquisitions, partnership strategy, and go-to-market efforts. Previous to Novartis, Dr. Sawhney was a partner and managing director at Boston Consulting Group, where he was responsible for their healthcare practices division and generated $150MM in engagements in the biopharma and medical device industry. Dr. Sawhney also founded and managed Avatar Capital, an early-stage fund that generated 6.2x cash-on-cash returns through successful exists such as Cvent's $1.5B IPO.
Dr. Sawhney studied economics at Stanford University and received his doctorate degree in medicine from Harvard University.
Executive Vice President at Frontage Labs ($40M in annual revenue). Dr. Lin leads the CRO's Bioanalytical and Biologics Services unit, commanding operations for the company's global bioanalytics labs. Previously, Dr. Lin was head of AstraZeneca Pharmaceuticals' global Drug Metabolism and Pharmokinetics division.
Dr. Lin studied chemistry at Jiangxi Normal College and received his doctorate degree in analytical chemistry from Dalhousie University. He completed his post-doctoral research in pharmacokinetics and drug metabolism at the College of Pharmacy and the Comprehensive Cancer Center of the Ohio State University.
Founder and CEO at Pieces Technologies, and inventor of the Piecesâ¢ DS software system. Inaugural Director of the Biomedical Informatics Program for the NIH CTSA at UTSW. Member of the HIMSS Board of Directors. Dr. Amarasingham has conducted and published studies in health IT evaluation, electronic medical records (EMR)-based enterprise-wide quality improvement, and real-time health predictive analysis, and he has won over $28M in extramural research funding in these areas.
Dr. Amarasingham studied at Brown University and received his doctorage degree in medicine from the University of Texas at Dallas. He was a Robert Wood clinical scholar at the Johns Hopkins University, where he focused on health service research and biomedical informatics.